ST. LOUIS--(BUSINESS WIRE)--The drug API Innovation Center today announced it has reached a milestone in the development of technology essential to accelerating the U.S. production of lomustine, a ...
Wuxi STA, a subsidiary of WuXi AppTec, continued its manufacturing expansion march with the opening of another high-potency active pharmaceutical ingredient (HPAPI) production facility in China. The ...
Cequence Security, the provider of unified API protection, is unveiling the latest testing capabilities—API Security Testing—for its unified API protection platform. Focused on pre-production ...
Novo Nordisk (NVO) has pledged DKK 42B ($6B) from 2023 through the next six years to expand production capacity in its home country. The investment will go into ramping up production at existing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback